Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2026-03-05 @ 6:29 AM
Study NCT ID:
NCT01830127
Status:
COMPLETED
Last Update Posted:
2015-11-20
First Post:
2013-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
None
Primary Completion Date:
2014-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-22
First Submit QC Date:
None
Study First Post Date:
2013-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-20
Results First Submit QC Date:
None
Results First Post Date:
2015-11-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-10-31
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-10-20
Last Update Post Date:
2015-11-20
Last Update Post Date Type:
ESTIMATED